| Literature DB >> 29541182 |
Shin-Ichi Oikawa1, Kiyoto Shiga1, Daisuke Saito1, Katsunori Katagiri1, Aya Ikeda1, Kodai Tuchida1, Jun Miyaguchi1, Kazuyuki Ishida2, Tamotsu Sugai2.
Abstract
The present study aimed to investigate the usefulness of contrast-enhanced ultrasonography (CEUS) and a newly developed analysis software for the detection of microcapillary network distribution in lymph nodes of patients with head and neck cancer (HNC) by comparing the CEUS and histopathological findings. Patients that were diagnosed with HNC between February and September 2016 were enrolled. A total of five patients underwent resection of the primary tumor and neck dissection as their initial treatment. The cervical lymph nodes of these patients were analyzed by CEUS intraoperatively, and their surgical specimens were examined histopathologically. The patients were diagnosed using a combination of physical examination, computed tomography, magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. For CEUS examination, the microbubble contrast agent Sonazoid™ was injected into a peripheral vein. Video images of the metastatic lymph nodes were captured, and these were subjected to analysis by a newly developed image-analysis software. It was possible to perform intraoperative CEUS of metastatic lymph nodes and obtain accurate matched sections for histopathological examination. Hematoxylin and eosin and cluster of differentiation (CD)34 staining revealed that the software was able to accurately detect capillary vessels in metastatic lymph nodes. However, a number of perfusion deficits were observed in these lymph nodes. In conclusion, by using CEUS with the analysis software, the density and distribution of blood vessels in the metastatic lymph nodes of patients with HNC was revealed. Although the present study was limited and preliminary, it was concluded that this method may be useful to evaluate and to map the capillary vessels in the metastatic lymph nodes of patients with HNC.Entities:
Keywords: Sonazoid™; cluster of differentiation 34; contrast-enhanced ultrasonography; head and neck cancer; histopathological findings; metastatic lymph node
Year: 2018 PMID: 29541182 PMCID: PMC5835891 DOI: 10.3892/ol.2018.7835
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Profiles of the patients and lymph nodes of interest.
| Patient | Age | Gender | Primary tumor | Stage[ | Lymph node of interest | Major axis, mm | Minor axis, mm | Thickness, mm |
|---|---|---|---|---|---|---|---|---|
| 1 | 71 | M | Larynx | T2N2bM0 | Left II | 15 | 11 | 11 |
| 2 | 75 | M | Hypopharynx | T3N2bM0 | Left III | 24 | 21 | 19 |
| 3 | 72 | M | Hypopharynx | T4aN2bM0 | Right III | 20 | 10 | 10 |
| 4 | 65 | M | Tongue | rN1 | Left II | 31 | 31 | 19 |
| 5 | 72 | M | Floor of the mouth | TN2bM0 | Left I | 31 | 15 | 10 |
Union for international cancer control tumor node metastasis (11); M, male.
Figure 1.Histopathological findings, clinical and ultrasound images of case 5. Enhanced CT images in the (A) coronal view and (B) axial view of the lymph node of interest. Fluorodeoxyglucose-positron emission tomography/CT images in the (C) coronal view and (D) axial view of the lymph node of interest. The yellow arrows indicate the lymph node of interest. (E) Ultrasound B-mode image of US including the major axis of the lymph node of interest. (F) Color Doppler image of the lymph node of interest. (G) CEUS and (H) analyzed CEUS images of the lymph node of interest. (I) H&E staining of the lymph node of interest including the major axis. Scale bar=4 mm. (J) The same image as H indicating the selected area of interest. Blue square, area of low contrast enhancement; orange square, area of high contrast enhancement. H&E staining of (K) area of low contrast enhancement and (L) area of high contrast enhancement. CD34 immunohistochemical staining of (M) area of low contrast enhancement and (N) area of high contrast enhancement. Original magnification, ×25 and scale bars=800 mm (K, L, M, and N). CT, computed tomography; CEUS, contrast enhanced ultrasonography; CD34, cluster of differentiation 34; H&E, hematoxylin and eosin.
Figure 2.Histopathological and analyzed CEUS images of the metastatic lymph nodes of patients. (A) H&E staining of metastatic lymph node section of case 1. (B) Analyzed CEUS image of case 1. (C) H&E staining of metastatic lymph node section of case 2. (D) Analyzed CEUS image of case 2. (E) H&E staining of metastatic lymph node section of case 3. (F) Analyzed CEUS image of case 3. (G) H&E staining of metastatic lymph node section of case 4. (H) Analyzed CEUS image of case 4. H&E, hematoxylin and eosin; CEUS, contrast enhanced ultrasonography. Scale bar in A, C, E, and G=4 mm.
Histopathological and ultrasonography image data of the lymph nodes.
| Patient | Necrosis | Normal lymph follicles | Color Doppler imaging-matched capillary vessels | CEUS-matched capillary vessels | Perfusion defect |
|---|---|---|---|---|---|
| 1 | − | + | + | ++ | ++ |
| 2 | − | − | − | ++ | + |
| 3 | + | − | + | ++ | + |
| 4 | +++ | − | − | ++ | − |
| 5 | + | + | + | ++ | ++ |
Necrosis: -; none, +; observed in under 20% of areas, ++; observed in 20~50% of areas, +++; observed in over 50% of areas. Normal lymph follicles: -; none, +; observed, Color Doppler imaging-matched capillary vessels; CEUS-matched capillary vessels: -; none, +; only thick vessels were detected, ++; thick vessels and peripheral thin vessels were detected. Perfusion defect: -; none, +; observed in <50% of areas, ++; observed in ≥50% of areas, except for necrotic areas. CEUS, contrast-enhanced ultrasonography.